Anxiety contributes to ongoing functional decline in PD and is a promising, treatable symptom that may improve outcomes. In this observational dataset, initiation of anxiety treatment was associated with a reduction in both MDS-UPDRS scores and PD medication use
Background: Anxiety symptoms are common in Parkinson disease (PD). Recent evidence suggests that anx...
INTRODUCTION: Anxiety and mild cognitive impairment (MCI) are prevalent non-motor manifestations of ...
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve...
Anxiety disturbances are recognized as common psychiatric comorbidities in Parkinson’s disease (PD) ...
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve...
Anxiety is understudied in Parkinson's disease (PD), which is not justified by the prevalence and im...
Anxiety is common in Parkinson's disease (PD), and contributes to increased disability and poorer qu...
Background: Anxiety disorders are common in Parkinson's disease (PD) and are undertreated. The curre...
Aim Anxiety has a negative impact on daily functioning and quality of life in patients with Parkinso...
Anxiety symptoms are common in Parkinson's disease (PD). A link between anxiety and cognitive impair...
Introduction Anxiety and mild cognitive impairment (MCI) are prevalent non-motor manifestations of P...
OBJECTIVE: Anxiety is a prominent concern in Parkinson's disease (PD) that negatively impacts qualit...
Anxiety disorders are common in Parkinson's disease (PD) patients, yet are poorly studied. We examin...
Objective: Anxiety is commonly endorsed in Parkinson\u27s disease (PD) and significantly affects qua...
Abstract: Anxiety syndromes are common in patients with Parkinson’s disease (PD) with up to 30 % suf...
Background: Anxiety symptoms are common in Parkinson disease (PD). Recent evidence suggests that anx...
INTRODUCTION: Anxiety and mild cognitive impairment (MCI) are prevalent non-motor manifestations of ...
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve...
Anxiety disturbances are recognized as common psychiatric comorbidities in Parkinson’s disease (PD) ...
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve...
Anxiety is understudied in Parkinson's disease (PD), which is not justified by the prevalence and im...
Anxiety is common in Parkinson's disease (PD), and contributes to increased disability and poorer qu...
Background: Anxiety disorders are common in Parkinson's disease (PD) and are undertreated. The curre...
Aim Anxiety has a negative impact on daily functioning and quality of life in patients with Parkinso...
Anxiety symptoms are common in Parkinson's disease (PD). A link between anxiety and cognitive impair...
Introduction Anxiety and mild cognitive impairment (MCI) are prevalent non-motor manifestations of P...
OBJECTIVE: Anxiety is a prominent concern in Parkinson's disease (PD) that negatively impacts qualit...
Anxiety disorders are common in Parkinson's disease (PD) patients, yet are poorly studied. We examin...
Objective: Anxiety is commonly endorsed in Parkinson\u27s disease (PD) and significantly affects qua...
Abstract: Anxiety syndromes are common in patients with Parkinson’s disease (PD) with up to 30 % suf...
Background: Anxiety symptoms are common in Parkinson disease (PD). Recent evidence suggests that anx...
INTRODUCTION: Anxiety and mild cognitive impairment (MCI) are prevalent non-motor manifestations of ...
In Parkinson's disease (PD), both the patient and the health care provider look for ways to preserve...